Defining the mechanism and functions of RIPK1-induced cell death in anti-bacterial immune defense

明确RIPK1诱导细胞死亡在抗菌免疫防御中的机制和功能

基本信息

  • 批准号:
    10329911
  • 负责人:
  • 金额:
    $ 56.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-01 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary Immune defense against bacterial infection requires signaling pathways that activate expression of inflammatory mediators to control and clear infection. Many pathogens inhibit these signaling pathways in order to evade host immune defenses. In particular, Yersinia injects a virulence factor, YopJ, which potently blocks key aspects of NF-ΚB and MAPK signaling pathways. How immune defense is mediated against pathogens that block immune signaling pathways remains poorly understood. NF-κB blockade in macrophages exposed to bacterial PAMPs leads to cell death. Importantly, our recently published data demonstrate that RIPK1 kinase activity is required for Yersinia-induced cell death, and that RIPK1 kinase activity is critical for resistance to Yersinia infection and innate inflammatory cytokine production in vivo. This suggests that RIPK1- induced death triggered by Yersinia is a key immune protective mechanism. Our new studies indicate that IKK phosphorylates RIPK1 to limit induction of cell death by inflammatory stimuli, suggesting that Yersinia blockade of IKK releases RIPK1 from this inhibitory effect. How RIPK1 kinase activity and cell death promote host defense against bacterial infection is not known. Our central hypothesis is that RIPK1-mediated cell death triggered in response to pathogen-mediated NF-κB and MAPK blockade releases pro-inflammatory signals, such as IL-1 cytokines and intracellular alarmins that enable uninfected bystander cells to produce key inflammatory mediators such as TNF, which control infection by pathogens that interfere with innate signaling. This is an important problem as this pathway likely responds to many pathogens that block critical innate immune signaling pathways and in the context of pathological stimuli that lead to RIPK1-induced cell death. We propose three Specific Aims to address this important gap in our knowledge. First we will define the molecular basis for how RIPK1 kinase activation occurs in response to YopJ blockade of IKK signaling, and test the role of this pathway in anti-bacterial immune defense. Second, we will define immune responses of infected and bystander cells, and will define the contribution of RIPK1-dependent cell death pathways to anti- bacterial host defense in vivo. Finally, we will determine the contribution of TNF signaling by bystander cells to antibacterial immune defense and will define the cell-type specific requirement for RIPK1- and TNFR- dependent cell death in host immune defense against Yersinia.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IGOR E BRODSKY其他文献

IGOR E BRODSKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IGOR E BRODSKY', 18)}}的其他基金

Defining mechanisms of Casp1/11-independent death triggered by clinical Salmonella Enteritidis
临床肠炎沙门氏菌触发的 Casp1/11 独立死亡的定义机制
  • 批准号:
    10452195
  • 财政年份:
    2022
  • 资助金额:
    $ 56.53万
  • 项目类别:
Defining mechanisms of Casp1/11-independent death triggered by clinical Salmonella Enteritidis
临床肠炎沙门氏菌触发的 Casp1/11 独立死亡的定义机制
  • 批准号:
    10580079
  • 财政年份:
    2022
  • 资助金额:
    $ 56.53万
  • 项目类别:
Lymphothrombosis in gut health and disease
肠道健康和疾病中的淋巴血栓形成
  • 批准号:
    10435528
  • 财政年份:
    2019
  • 资助金额:
    $ 56.53万
  • 项目类别:
Defining the mechanism and functions of RIPK1-induced cell death in anti-bacterial immune defense
明确RIPK1诱导细胞死亡在抗菌免疫防御中的机制和功能
  • 批准号:
    10092916
  • 财政年份:
    2019
  • 资助金额:
    $ 56.53万
  • 项目类别:
Lymphothrombosis in gut health and disease
肠道健康和疾病中的淋巴血栓形成
  • 批准号:
    10200805
  • 财政年份:
    2019
  • 资助金额:
    $ 56.53万
  • 项目类别:
Lymphothrombosis in gut health and disease
肠道健康和疾病中的淋巴血栓形成
  • 批准号:
    10649640
  • 财政年份:
    2019
  • 资助金额:
    $ 56.53万
  • 项目类别:
Defining the mechanism and functions of RIPK1-induced cell death in anti-bacterial immune defense
明确RIPK1诱导细胞死亡在抗菌免疫防御中的机制和功能
  • 批准号:
    10557104
  • 财政年份:
    2019
  • 资助金额:
    $ 56.53万
  • 项目类别:
Lymphothrombosis in gut health and disease
肠道健康和疾病中的淋巴血栓形成
  • 批准号:
    10018488
  • 财政年份:
    2019
  • 资助金额:
    $ 56.53万
  • 项目类别:
Defining the non-apoptotic role of Caspase-8 activity in anti-bacterial immune defense
定义 Caspase-8 活性在抗菌免疫防御中的非凋亡作用
  • 批准号:
    9229681
  • 财政年份:
    2017
  • 资助金额:
    $ 56.53万
  • 项目类别:
Dissecting the mechanism of RIPK1 kinase-dependent cell death in control of Yersinia infection
剖析 RIPK1 激酶依赖性细胞死亡控制耶尔森菌感染的机制
  • 批准号:
    9285729
  • 财政年份:
    2016
  • 资助金额:
    $ 56.53万
  • 项目类别:

相似海外基金

New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
  • 批准号:
    1654774
  • 财政年份:
    2015
  • 资助金额:
    $ 56.53万
  • 项目类别:
    Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8416313
  • 财政年份:
    2012
  • 资助金额:
    $ 56.53万
  • 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8298885
  • 财政年份:
    2012
  • 资助金额:
    $ 56.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了